PRODUCTS
APIs and intermediates
Number of views:
1000

Temozolomide

Temozolomide is the first oral effective imidazo tetrazine antitumor drug. It belongs to the second generation alkylating agent with antitumor activity.
Retail price
0.0
Market price
0.0
Number of views:
1000
CAS:

85622-93-1
Standard:

USP/BP
Purity:

Quantity
-
+
Stock:
0
Product description
Parameters

Product Intro

Temozolomide is the first oral effective imidazo tetrazine antitumor drug. It belongs to the second generation alkylating agent with antitumor activity. It does not need intrahepatic metabolic activation after oral administration. It is characterized by easy penetration through the blood-brain barrier, good tolerance and no superimposed toxicity with other drugs. It has synergistic effect with radiotherapy. It is suitable for malignant gliomas that relapse after routine treatment, For example, glioblastoma multiforme or degenerative astrocytoma is also the first-line drug for the treatment of metastatic melanoma.


Function

It can degrade spontaneously and quickly in vivo to produce the active metabolite mtic and produce antitumor effect. Uses: used as antitumor drugs.
Application

This product is suitable for the treatment of adult patients with intractable pleomorphic glioblastoma.

Keyword:
Temozolomide
CAS 85622-93-1
API
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
NORKY

Copyright © Shanghai Norky Pharmaceutical Co., Ltd. All Rights Reserved        沪ICP备20013299号        Powered by www.300.cn